Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First Trimester Risk Assessment Based on Ultrasound and Cell-free DNA vs Combined Screening: Women's Experience

NCT04077060 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT04077060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04077060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First Trimester Risk Assessment Based on Ultrasound and Cell-free DNA vs Combined Screening: Women's Experience
Lead sponsor
Federico II University
Phase
Not applicable
Overall status
Completed
Start date
August 26, 2019
Completion date
February 15, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aneuploidy